XML 37 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Dec. 31, 2016
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis as of December 31, 2016:
 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
20,893

 
$
20,893

 
$

 
$

Forward foreign currency exchange contracts
642

 

 
642

 

Total assets at fair value
$
21,535

 
$
20,893

 
$
642

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
20,893

 
$
20,893

 
$

 
$

Forward foreign currency exchange contracts
115

 

 
115

 

Liability for contingent consideration, current and non-current portion
110,880

 

 

 
110,880

Total liabilities at fair value
$
131,888

 
$
20,893

 
$
115

 
$
110,880




















The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2016:
 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
17,893

 
$
17,893

 
$

 
$

Forward foreign currency exchange contracts
33

 

 
33

 

Total assets at fair value
$
17,926

 
$
17,893

 
$
33

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
17,893

 
$
17,893

 
$

 
$

Forward foreign currency exchange contracts
551

 

 
551

 

Liability for contingent consideration, current and non-current portion
24,652

 

 

 
24,652

Total liabilities at fair value
$
43,096

 
$
17,893

 
$
551

 
$
24,652

Summary of Changes in Fair Value of Contingent Considerations
The table below provides a summary of the changes in fair value of the Company’s contingent considerations (Level 3) for the Imago ScanSource, Network1 and Intelisys earnouts for the quarter and six months ended December 31, 2016:
 
Contingent consideration for the quarter ended
 
Contingent consideration for the six months ended
 
December 31, 2016
 
December 31, 2016
 
Communications & Services Segment
 
Communications & Services Segment
 
(in thousands)
Fair value at beginning of period
$
110,835

 
$
24,652

Issuance of contingent consideration

 
95,000

Payments
(1,607
)
 
(10,241
)
Change in fair value of contingent consideration
1,791

 
1,961

Foreign currency translation adjustment
(139
)
 
(492
)
Fair value at end of period
$
110,880

 
$
110,880



The table below provides a summary of the changes in fair value of the Company’s contingent considerations (Level 3) for the CDC, Imago ScanSource, and Network1 earnouts for the quarter and six months ended December 31, 2015:
 
Contingent consideration for the quarter ended
 
Contingent consideration for the six months ended
 
December 31, 2015
 
December 31, 2015
 
Barcode, Networking & Security Segment
 
Communications & Services Segment
 
Total
 
Barcode, Networking & Security Segment
 
Communications & Services Segment
 
Total
 
(in thousands)
Fair value at beginning of period
$
4,114

 
$
24,943

 
$
29,057

 
$
5,109

 
$
28,851

 
$
33,960

Payments
(3,133
)
 
(4,153
)
 
(7,286
)
 
(3,133
)
 
(4,153
)
 
(7,286
)
Change in fair value of contingent consideration

 
1,816

 
1,816

 
126

 
3,255

 
3,381

Foreign currency translation adjustment
175

 
238

 
413

 
(946
)
 
(5,109
)
 
(6,055
)
Fair value at end of period
$
1,156

 
$
22,844

 
$
24,000

 
$
1,156

 
$
22,844

 
$
24,000

Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for our contingent consideration liabilities as of December 31, 2016 and June 30, 2016 were as follows.

Reporting Period
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted Average Rates
December 31, 2016
 
Discounted cash flow
 
Weighted average cost of capital
 
15.2
%
 
 
 
 
Adjusted EBITDA growth rate
 
30.4
%
 
 
 
 
 
 
 
June 30, 2016
 
Discounted cash flow
 
Weighted average cost of capital
 
17.7
%
 
 
 
 
Adjusted EBITDA growth rate
 
44.0
%